Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02727543 · ClinicalTrials.gov registry record · NA
Medication Adherence Improvement Support App For Engagement - Blood Pressure
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 413
- Enrollment target
NCT02727543 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 413 participants.
The verdict
NCT02727543, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 413 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the impact of the Medisafe smartphone application on blood pressure control and self-reported medication adherence for patients with uncontrolled blood pressure.
Interventions
- OTHER Medisafe
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 413 participants |
| Start Date | 2016-04 |
| Est. Completion | 2017-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02727543
The ClinicalTrials.gov registry entry for NCT02727543 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 413 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brigham and Women's Hospital, which has 937 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Medisafe is the first listed.
NCT02727543 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02727543 about?
NCT02727543 is a clinical study titled "Medication Adherence Improvement Support App For Engagement - Blood Pressure". The purpose of this study is to evaluate the impact of the Medisafe smartphone application on blood pressure control and self-reported medication adherence for patients with uncontrolled blood pressure.
What is the current status of trial NCT02727543?
This trial is currently completed. It is a NA study. The enrollment target is 413 participants. The study started on 2016-04. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02727543?
The interventions under investigation include: Medisafe (OTHER).
Who is sponsoring clinical trial NCT02727543?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.